BMS Elects New CEO

James M. Cornelius, who has served as interim chief executive for the past eight months, has been elected chief executive officer of Bristol-Myers Squibb Company (New York, NY, www.bms.com) with a term through the date of the company’s annual meeting of stockholders in 2009. Cornelius has been a member of the BMS board since January 2007. Before joining BMS, he was the chief financial officer of Eli Lilly and Company.